NDRA
ENDRA Life Sciences Inc.
There isn't enough reported data to score NDRA yet.
NDRA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
NDRA's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
NDRA PE Valuation
NDRA has no meaningful PE right now: it lost money over the past year.
NDRA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect NDRA's losses to shrink, with revenue declining.
NDRA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2020 | -$64,400.00 | -$14,700.00 |
NDRA is still losing money, but far less than before: $8,938.08 per share over the past year, against $81,900.00 at its worst in late 2019.
NDRA Quarterly Revenue
NDRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.6M | -$96K |
| Q3 2025 | -$1.2M | +$493.2K |
| Q2 2025 | -$1.1M | +$958.6K |
| Q1 2025 | -$1.3M | +$860.9K |
| Q4 2024 | -$1.5M | +$665.8K |
| Q3 2024 | -$1.7M | +$941.5K |
| Q2 2024 | -$2.1M | +$196.3K |
| Q1 2024 | -$2.2M | +$362.5K |
NDRA has burned cash in almost every quarter: −$5M over the past year, against −$7M the year before.
NDRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +556% | +35.1K shares |
| 1 year | +868% | +37.1K shares |
| 3 years | +3376% | +40.2K shares |
NDRA has 41,394 diluted shares, up 868% from a year ago.
NDRA Net Leverage
NDRA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NDRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.6 | Neutral |
| Stochastic | 25.3 | Neutral |
NDRA's weekly RSI is 45 (neutral) and its Stochastic is 25 (neutral).
NDRA PE vs Healthcare Sector
NDRA has no meaningful PE right now: it lost money over the past year.
NDRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.15 | 9.9% below |
| 20 week MA | $5.09 | 8.8% below |
| 50 week MA | $4.82 | 3.7% below |
| 100 week MA | $4.82 | 3.7% below |
| 200 week MA | $979.1 | 100% below |
NDRA is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
NDRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48,300.0 | $26,775.0 | -45% |
| 2021 | $26,775.0 | $29,155.0 | +8.9% |
| 2022 | $29,155.0 | $9,432.5 | -68% |
| 2023 | $9,432.5 | $3,710.0 | -61% |
| 2024 | $3,710.0 | $6.30 | -100% |
| 2025 | $6.30 | $5.08 | -19% |
| 2026 YTD | $5.08 | $4.64 | -8.7% |
NDRA has finished four years in a row lower, and it's down 8.7% so far in 2026.